We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$13B
AUM Growth
+$1.56B
Cap. Flow
+$261M
Cap. Flow %
2.02%
Top 10 Hldgs %
17.05%
Holding
1,179
New
174
Increased
377
Reduced
434
Closed
179

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$128M
2
EA icon
Electronic Arts
EA
+$79.4M
3
BMY icon
Bristol-Myers Squibb
BMY
+$75M
4
TGT icon
Target
TGT
+$74.4M
5
AMZN icon
Amazon
AMZN
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 22.12%
2 Healthcare 14.04%
3 Consumer Discretionary 13.03%
4 Financials 12.63%
5 Industrials 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FISI icon
726
Financial Institutions
FISI
$812M
$1.06M 0.01%
35,139
-135
-0.4% -$3.65K
LEE icon
727
Lee Enterprises
LEE
$175M
$1.06M 0.01%
+41,298
New +$825K
CORR
728
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$1.06M 0.01%
+149,387
New +$1.19M
IVAC
729
DELISTED
Intevac Inc
IVAC
$1.03M 0.01%
144,415
+97,668
+209% +$652K
STSA
730
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$1.03M 0.01%
174,396
-21,255
-11% -$129K
APRE icon
731
Aprea Therapeutics
APRE
$7.69M
$1.02M 0.01%
+10,018
New +$1.17M
LFVN icon
732
LifeVantage
LFVN
$80.1M
$1.02M 0.01%
109,339
-9,873
-8% -$92.1K
RUBY
733
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.02M 0.01%
38,546
-356,363
-90% -$5.21M
GLRE icon
734
Greenlight Captial
GLRE
$579M
$1.02M 0.01%
116,805
+47,749
+69% +$391K
SYBX
735
DELISTED
Synlogic
SYBX
$1.01M 0.01%
18,841
+2,258
+14% +$129K
SNX icon
736
TD Synnex
SNX
$19.9B
$1.01M 0.01%
8,801
-20,955
-70% -$1.96M
HZN
737
DELISTED
Horizon Global Corporation
HZN
$1.01M 0.01%
97,883
+62,706
+178% +$603K
CATO icon
738
Cato Corp
CATO
$65.7M
$1.01M 0.01%
+83,869
New +$987K
GTS
739
DELISTED
Triple-S Management Corporation
GTS
$1M 0.01%
38,586
+25,729
+200% +$635K
INFI
740
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$993K 0.01%
307,533
+165,179
+116% +$551K
ATRA icon
741
Atara Biotherapeutics
ATRA
$72.6M
$988K 0.01%
+2,751
New +$1.22M
CCBG icon
742
Capital City Bank Group
CCBG
$897M
$988K 0.01%
37,965
-1,599
-4% -$40.5K
CARE icon
743
Carter Bankshares
CARE
$765M
$968K 0.01%
69,358
-1,725
-2% -$20.9K
CYPH
744
Cypherpunk Technologies Inc
CYPH
$64M
$961K 0.01%
50,567
+27,779
+122% +$662K
AMR icon
745
Alpha Metallurgical Resources
AMR
$1.77B
$955K 0.01%
75,629
+30,550
+68% +$417K
GTHX
746
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$945K 0.01%
39,286
-88,797
-69% -$2.06M
IWO icon
747
iShares Russell 2000 Growth ETF
IWO
$14.1B
$944K 0.01%
3,139
-350
-10% -$109K
SPOK icon
748
Spok Holdings
SPOK
$229M
$942K 0.01%
89,794
+36,067
+67% +$413K
SAGE
749
DELISTED
Sage Therapeutics
SAGE
$937K 0.01%
12,520
-222,419
-95% -$18.2M
SCPH
750
DELISTED
scPharmaceuticals
SCPH
$937K 0.01%
140,967
+114,803
+439% +$787K

Similar funds

Jacobs Levy Equity Management's Q1 2021 Portfolio in Review

As of Q1 2021, Jacobs Levy Equity Management held 1,179 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Jacobs Levy Equity Management's Q1 2021 filing shows 174 new, 377 increased, 434 reduced and 179 closed positions. Its largest new stake was Target: 397,775 shares worth $78.8M. The largest sale was Microsoft, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q1 2021 buy was Target: 397,775 shares worth $78.8M.
  • Jacobs Levy Equity Management added most to Costco in Q1 2021, an estimated $128M increase.
  • Jacobs Levy Equity Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
  • Jacobs Levy Equity Management fully exited Starbucks in Q1 2021, selling an estimated $121M.
  • Jacobs Levy Equity Management's ten largest holdings make up 17% of its $13B portfolio in Q1 2021.
  • Jacobs Levy Equity Management opened 174 new positions and closed 179 in Q1 2021.
  • Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $13B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2021, filed 17 May 2021.